Boston Partners Pet Iq, Inc. Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Pet Iq, Inc. stock. As of the latest transaction made, Boston Partners holds 31,620 shares of PETQ stock, worth $979,587. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,620

Previous 1,039,987 96.96%

Holding current value

$979,587

Previous $22.9 Million 95.76%

% of portfolio

0.0%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$20.57 - $30.79 $20.7 Million - $31 Million	-1,008,367 Reduced 96.96%	31,620 $972,000
Q2 2024 Aug 13, 2024	SELL	$15.93 - $22.26 $441,101 - $616,379	-27,690 Reduced 2.59%	1,039,987 $22.9 Million
Q1 2024 May 13, 2024	BUY	$15.55 - $19.42 $1.05 Million - $1.32 Million	67,797 Added 6.78%	1,067,677 $19.5 Million
Q4 2023 Feb 07, 2024	SELL	$17.18 - $22.38 $878,550 - $1.14 Million	-51,138 Reduced 4.87%	999,880 $19.7 Million
Q3 2023 Nov 07, 2023	SELL	$15.0 - $20.71 $676,845 - $934,497	-45,123 Reduced 4.12%	1,051,018 $20.7 Million
Q2 2023 Aug 10, 2023	SELL	$10.84 - $15.43 $315,498 - $449,090	-29,105 Reduced 2.59%	1,096,141 $16.6 Million
Q1 2023 May 09, 2023	SELL	$9.32 - $12.58 $4.01 Million - $5.42 Million	-430,482 Reduced 27.67%	1,125,246 $12.9 Million
Q4 2022 Feb 07, 2023	SELL	$6.82 - $12.07 $127,240 - $225,189	-18,657 Reduced 1.19%	1,555,728 $14.3 Million
Q3 2022 Nov 09, 2022	SELL	$6.9 - $18.16 $298,231 - $784,911	-43,222 Reduced 2.67%	1,574,385 $11.2 Million
Q2 2022 Aug 10, 2022	BUY	$14.09 - $25.12 $664,061 - $1.18 Million	47,130 Added 3.0%	1,617,607 $27.2 Million
Q1 2022 May 10, 2022	BUY	$17.92 - $24.4 $523,353 - $712,602	29,205 Added 1.89%	1,570,477 $38.3 Million
Q4 2021 Feb 04, 2022	BUY	$19.97 - $25.91 $6.53 Million - $8.48 Million	327,174 Added 26.95%	1,541,272 $34.8 Million
Q3 2021 Nov 05, 2021	BUY	$23.99 - $38.59 $29.1 Million - $46.9 Million	1,214,098 New	1,214,098 $30.3 Million
Q2 2021 Aug 12, 2021	SELL	$34.94 - $45.35 $3.77 Million - $4.9 Million	-107,966 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$32.6 - $37.82 $257,051 - $298,210	-7,885 Reduced 6.81%	107,966 $3.81 Million
Q4 2020 Feb 04, 2021	BUY	$24.99 - $38.45 $413,784 - $636,655	16,558 Added 16.68%	115,851 $4.46 Million
Q3 2020 Nov 13, 2020	BUY	$29.04 - $37.49 $1.06 Million - $1.37 Million	36,413 Added 57.91%	99,293 $3.27 Million
Q2 2020 Aug 12, 2020	SELL	$20.16 - $34.84 $1.7 Million - $2.94 Million	-84,515 Reduced 57.34%	62,880 $2.19 Million
Q1 2020 May 13, 2020	SELL	$16.59 - $34.94 $608,919 - $1.28 Million	-36,704 Reduced 19.94%	147,395 $3.42 Million
Q4 2019 Feb 05, 2020	BUY	$22.24 - $27.56 $1.26 Million - $1.56 Million	56,759 Added 44.57%	184,099 $4.61 Million
Q3 2019 Nov 20, 2019	BUY	$25.56 - $36.1 $693,545 - $979,537	27,134 Added 27.08%	127,340 $3.47 Million
Q2 2019 Aug 09, 2019	BUY	$24.79 - $32.96 $31,384 - $41,727	1,266 Added 1.28%	100,206 $3.3 Million
Q1 2019 May 03, 2019	BUY	$23.31 - $31.41 $2.31 Million - $3.11 Million	98,940 New	98,940 $3.11 Million
Q3 2018 Nov 14, 2018	SELL	$25.67 - $42.36 $3.9 Million - $6.44 Million	-152,010 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$17.91 - $26.86 $2.72 Million - $4.08 Million	152,010 New	152,010 $4.08 Million

Others Institutions Holding PETQ

# of Institutions

190

Shares Held

30.1M

Call Options Held

81K

Put Options Held

113K

View Full List

About PetIQ, Inc.

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

More about PETQ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account